Development of peptide antagonists that target estrogen receptor-cofactor interactions (Q34132677)

31 July 2017

1 reference

title

Development of peptide antagonists that target estrogen receptor-cofactor interactions (English)

1 reference

31 July 2017

McDonnell DP

1

1 reference

PubMed ID

11162941

31 July 2017

Chang CY

series ordinal

2

1 reference

PubMed ID

11162941

31 July 2017

Norris JD

series ordinal

3

1 reference

31 July 2017

1 November 2000

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

31 July 2017

1 reference

31 July 2017

74

1 reference

31 July 2017

5

1 reference

31 July 2017

327-335

1 reference

Cloning of a novel receptor expressed in rat prostate and ovary

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Nuclear receptor coregulators: cellular and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Steroid receptor coactivator-1 is a histone acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Anti-estrogens come of age: a pioneer looks back

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

How is tamoxifen's action subverted?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Comparative analyses of mechanistic differences among antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

A canonical structure for the ligand-binding domain of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Identification of novel human WW domain-containing proteins by cloning of ligand targets

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Peptide antagonists of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns].

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

Small peptides as potent mimetics of the protein hormone erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900109-6

7 January 2021

10.1016/S0960-0760(00)00109-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11162941